| Literature DB >> 25271085 |
Beatriz Paumard-Hernández1, Julia Berges-Soria1, Eva Barroso2, Carlos I Rivera-Pedroza1, Virginia Pérez-Carrizosa1, Sara Benito-Sanz2, Eva López-Messa1, Fernando Santos2, Ignacio I García-Recuero3, Ana Romance3, Juliana María Ballesta-Martínez4, Vanesa López-González4, Ángel Campos-Barros2, Jaime Cruz5, Encarna Guillén-Navarro6, Jaime Sánchez Del Pozo5, Pablo Lapunzina2, Sixto García-Miñaur2, Karen E Heath2.
Abstract
Craniosynostosis, caused by the premature fusion of one or more of the cranial sutures, can be classified into non-syndromic or syndromic and by which sutures are affected. Clinical assignment is a difficult challenge due to the high phenotypic variability observed between syndromes. During routine diagnostics, we screened 182 Spanish craniosynostosis probands, implementing a four-tiered cascade screening of FGFR2, FGFR3, FGFR1, TWIST1 and EFNB1. A total of 43 variants, eight novel, were identified in 113 (62%) patients: 104 (92%) detected in level 1; eight (7%) in level 2 and one (1%) in level 3. We subsequently screened additional genes in the probands with no detected mutation: one duplication of the IHH regulatory region was identified in a patient with craniosynostosis Philadelphia type and five variants, four novel, were identified in the recently described TCF12, in probands with coronal or multisuture affectation. In the 19 Saethre-Chotzen syndrome (SCS) individuals in whom a variant was detected, 15 (79%) carried a TWIST1 variant, whereas four (21%) had a TCF12 variant. Thus, we propose that TCF12 screening should be included for TWIST1 negative SCS patients and in patients where the coronal suture is affected. In summary, a molecular diagnosis was obtained in a total of 119/182 patients (65%), allowing the correct craniosynostosis syndrome classification, aiding genetic counselling and in some cases provided a better planning on how and when surgical intervention should take place and, subsequently the appropriate clinical follow up.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25271085 PMCID: PMC4463497 DOI: 10.1038/ejhg.2014.205
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246